KRAS and colorectal carcinoma: All examined CRC cell lines were equally sensitive to VPA treatment, independently from their intrinsic characteristics such as p53, KRAS, BRAF, PI3KCA status (Table 1), the basal expression of TS and TP proteins, or the basal histone-H3 acetylation (AcH3) (Fig. 1a).